SEBI Reg. Investment Advisor

Download App

Help Center Pricing

Recent:

Glenmark Pharmaceuticals, Jubilant Pharmova and JB Chemicals to see some action today

AMJ Land Holdings Ltd. | Construction - Real Estate | Construction & Infrastructure | BSE: 500343 | NSE: AMJLAND

01 Jun 2021 Evaluate

Glenmark Pharmaceuticals (Glenmark) has launched Rufinamide Tablets USP, 200 mg and 400 mg, a therapeutic equivalent of Banzel Tablets, 200 mg and 400 mg of Eisai, Inc. Glenmark was one of the first ANDA applicants to submit a substantially complete ANDA for Rufinamide Tablets USP, 200 mg and 400 mg, with a paragraph IV certification and received final approval on May 16, 2016.

Jubilant Pharma, a wholly-owned subsidiary of Jubilant Pharmova is planning to invest $92 Million to expand sterile injectable manufacturing capacity at its Spokane site in Washington, US. This investment is being made to set up a high speed 400 vials a minute injectable fill line with isolator technology, which will enhance the Spokane facility’s capacity by 50%. This expansion will also include two 300 sq feet Lyophilizers. This expansion will be spread over 50,000 sq feet at the Spokane facility and will be commercially operational by the end CY24.

JB Chemicals & Pharmaceuticals has launched medicated nicotine lozenges that will help reduce the urge to consume or smoke tobacco. On the occasion of 'World No Tobacco Day', the drug maker has also launched an Artificial Intelligence-enabled chatbot 'Dr Will', which would encourage and support tobacco smokers to quit smoking.

AMJ Land Holdings has received approval for the sale of its entire shareholding in GCORP AMJ Land Township, a joint venture of the company in view of current business situation, subject to execution of necessary agreement and other documents. After execution of aforesaid agreement, the GCORP AMJ Land Township will cease to be the company's joint venture company.

Ashiana Housing’s board has allotted 970 Un-Secured, Redeemable, Non-Convertible Debentures on Private Placement basis for an amount of Rs 97 crore. The Executive Committee of Directors on May 31, 2021 have allotted the same.

NLC India has raised Rs 300 crore through Commercial Paper and allotted 6000 Nos. of Commercial Paper of a face value of Rs 5 lakh each on May 31, 2021.

SKF India is planning to offer COVID-19 support for employees and their immediate family members in the unfortunate event of an employee succumbing to the coronavirus infection. As part of these measures, the company will provide life insurance cover for the next three years and education support for two children up to 12th grade. Besides, SKF will also provide one-time financial assistance of Rs 5 lakh to the dependents of the blue-collar employee.

AMJ Land Holdings Share Price

44.31 1.38 (3.21%)

17-Apr-2026 16:59 View Price Chart

Peers

Company Name	CMP
Lodha Developers	871.70
Dilip Buildcon	457.55
DLF	601.80
Oberoi Realty	1710.00
Ahluwalia Contract(I	832.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

PROPRIETARY FRAMEWORK

Portfolio
Architecture >
Stock Picking.

Stop managing a collection of "tips." Access the ABC Framework to build a portfolio that survives cycles and compounds wealth.

Core for Stability

Booster for Alpha

Amplifier for Exponential Wealth

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Access Sapphire ABC Strategy →

Limited Capacity for New Fiduciary Partners

Glenmark Pharmaceuticals, Jubilant Pharmova and JB Chemicals to see some action today

MoneyWorks4Me Premium

Follow us at

MoneyWorks4Me

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.